RVMD vs ESLT

Comparison between Revolution Medicines Inc (RVMD, Company) and Elbit Systems Ltd (ESLT, Company).

RVMD is from the Healthcare sector, while ESLT is from the Industrials sector.

5-Year PerformanceESLT has outperformed RVMD, delivering a return of +46.3% compared to +45.5%

RVMD vs ESLT - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RVMD(COMPANY)	ESLT(COMPANY)
Market Cap	$37B	$37B
Max Drawdown	73.29%	58.03%
Sharpe Ratio	2.63	1.53
5Y Beta	1.09	0.32
Industry	Biotechnology	Aerospace & Defense
P/E Ratio	-25.95	68.90
Forward P/E	N/A	9.66
PEG Ratio	-0.33	1.16
Dividend Yield	N/A	0.52%
5Y Dividends CAGR	N/A	18.43%
5Y EPS CAGR	30.12%	16.43%
Debt to Equity	0.00%	2.46%
Free Cash Flow Yield	-2.93%	1.50%
P/S Ratio	9035.10	4.51
P/B Ratio	26.00	8.50

Market Cap

RVMD

$37B

Winner

ESLT

$37B

Max Drawdown

RVMD

73.29%

Winner

ESLT

58.03%

Sharpe Ratio

Winner

RVMD

2.63

ESLT

1.53

5Y Beta

RVMD

1.09

Winner

ESLT

0.32

Industry

RVMD

Biotechnology

ESLT

Aerospace & Defense

P/E Ratio

Winner

RVMD

-25.95

ESLT

68.90

Forward P/E

RVMD

N/A

ESLT

9.66

PEG Ratio

Winner

RVMD

-0.33

ESLT

1.16

Dividend Yield

RVMD

N/A

ESLT

0.52%

5Y Dividends CAGR

RVMD

N/A

ESLT

18.43%

5Y EPS CAGR

Winner

RVMD

30.12%

ESLT

16.43%

Debt to Equity

Winner

RVMD

0.00%

ESLT

2.46%

Free Cash Flow Yield

RVMD

-2.93%

Winner

ESLT

1.50%

P/S Ratio

RVMD

9035.10

Winner

ESLT

4.51

P/B Ratio

RVMD

26.00

Winner

ESLT

8.50

RVMD vs ESLT - Historical Returns

Returns include dividend reinvestment.

Period	RVMD	ESLT
1 month	+11.35%	+4.68%
3 months	+40.36%	-5.01%
6 months	+60.46%	+12.73%
1 year	+402.93%	+82.24%
5 years(CAGR)	+45.51%	+46.30%
10 years(CAGR)	N/A	+25.16%
Max(CAGR)	+33.83%	+18.35%

Winner

RVMD

+11.35%

ESLT

+4.68%

Winner

RVMD

+40.36%

ESLT

-5.01%

Winner

RVMD

+60.46%

ESLT

+12.73%

Winner

RVMD

+402.93%

ESLT

+82.24%

5Y(CAGR)

RVMD

+45.51%

Winner

ESLT

+46.30%

10Y(CAGR)

RVMD

N/A

ESLT

+25.16%

Max(CAGR)

Winner

RVMD

+33.83%

ESLT

+18.35%

RVMD vs ESLT - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	RVMD	ESLT
2026	+138.86%	+36.92%
2025	+81.02%	+121.45%
2024	+54.94%	+22.72%
2023	+24.97%	+28.21%
2022	-8.94%	-5.26%
2021	-33.64%	+35.58%
2020	+36.99%	-16.25%
2019	N/A	+36.16%
2018	N/A	-14.81%
2017	N/A	+32.61%
2016	N/A	+19.49%
2015	N/A	+50.60%
2014	N/A	+4.43%
2013	N/A	+49.79%
2012	N/A	+0.64%
2011	N/A	-22.47%
2010	N/A	-16.51%
2009	N/A	+40.90%
2008	N/A	-23.18%
2007	N/A	+75.14%
2006	N/A	+27.62%
2005	N/A	-6.27%
2004	N/A	+61.57%
2003	N/A	+17.06%
2002	N/A	-10.87%
2001	N/A	+45.96%
2000	N/A	-17.41%
1999	N/A	-1.05%

RVMD vs ESLT Drawdown Comparison

The maximum drawdown for RVMD was -73.29%, occurring on May 12, 2022. Recovery took 940 trading sessions.

The maximum drawdown for ESLT was -53.81%, occurring on Aug 28, 2012. Recovery took 1147 trading sessions.

The current RVMD drawdown is -2.01%. The current ESLT drawdown is -20.09%.

Rank	RVMD	ESLT
#1	-73.29% Feb 8, 2021 - Nov 1, 2024	-53.81% Aug 25, 2009 - Mar 18, 2014
#2	-48.63% Nov 11, 2024 - Nov 6, 2025	-42.26% Feb 1, 2008 - Jun 1, 2009
#3	-42.53% Jun 22, 2020 - Oct 6, 2020	-42.24% Mar 1, 2000 - Oct 5, 2001
#4	-42.34% Mar 4, 2020 - May 5, 2020	-32.89% Aug 12, 2022 - Nov 12, 2024
#5	-33.63% Oct 16, 2020 - Feb 2, 2021	-32.48% Dec 11, 2019 - Dec 14, 2021
#6	-24.95% Jan 15, 2026 - Apr 13, 2026	-29.27% Mar 17, 2026 - Jun 26, 2026
#7	-20.32% May 7, 2020 - Jun 15, 2020	-26.86% Oct 16, 2017 - Jun 11, 2019
#8	-13.68% Apr 15, 2026 - May 21, 2026	-24.45% Oct 8, 2001 - May 12, 2003
#9	-11.91% Jun 1, 2026 - Jun 22, 2026	-22.75% Jun 20, 2003 - Jan 20, 2004
#10	-6.98% Jun 29, 2026 - Jul 16, 2026	-20.82% Jan 3, 2005 - Jan 26, 2006
#11	-5.89% Jun 15, 2020 - Jun 22, 2020	-18.92% Mar 28, 2022 - Aug 3, 2022
#12	-5.73% Feb 26, 2020 - Mar 4, 2020	-15.13% Aug 6, 2015 - Nov 12, 2015
#13	-5.12% Dec 8, 2025 - Dec 22, 2025	-14.43% Jul 9, 2007 - Sep 4, 2007
#14	-3.52% Dec 24, 2025 - Jan 7, 2026	-14.12% May 12, 2003 - Jun 16, 2003
#15	-3.15% Nov 28, 2025 - Dec 4, 2025	-13.43% Oct 6, 2025 - Dec 17, 2025